Arkolith/Insider Trading/ARTV/Form 4

Ra Capital Management, L.P.

Director, 10% OwnerArtiva Biotherapeutics, Inc. (ARTV) · full profile →Form 4 · filed Jul 14, 2026
Net Buying
Open-Market Buys
$194K
Open-Market Sells
$0
Net Open-Market Flow
$194K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 13, 2026Buy(P)7K$8.94$59K16.8M
Jul 10, 2026Buy(P)15K$8.97$135K16.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000764) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML